Health care professionals are overcoming these obstacles with a new treatment called hepatic artery infusion pump chemotherapy that shrinks liver tumors, giving more people a chance for surgery. This treatment also can shrink tumors in the bile ducts inside the liver, called intrahepatic cholangiocarcinoma.
“Our goal is to expand the number of patients who could be offered curative treatment,” says Dr. Thiels. “We are also aiming to reduce the risk of cancer recurring in people with high-risk liver tumors.”
The hepatic artery carries oxygen-rich blood to the liver. A hepatic artery pump delivers chemotherapy directly into the liver’s blood supply. Because chemotherapy from the pump only reaches the liver, the approach can use higher doses to shrink liver tumors more effectively. “We can often achieve a higher response rate than conventional chemotherapy,” says Dr. Thiels.
Comments are closed.